Julian Upton

One company’s approach to recruiting and managing talent in an increasingly competitive marketplace.

Madeline Coffin, Senior VP of Human Resources at Alkermes, on why the best mentorship programs are those that are developed in an organic way and customized to each person’s growth and development goals.

Perspectives from big pharma and the rare disease space on how patient advocacy is evolving as a corporate function.

Jean Drouin M.D., CEO of Clarify Health Solutions, gives Pharm Exec his perspective on how biopharmaceutical companies are faring in the use of AI and machine learning

Scott Williams, Merck KGaA, Darmstadt, Germany’s Vice President, Head of Global Patient Advocacy and Strategic Partnerships, talks about the Embracing Carers initiative’s objectives and how its success is being measured.

This month's DIA Europe meeting saw the patient voice turned up to high volume, with advocates, regulators and industry representatives pushing the patient empowerment and engagement line.

Kilian Weiss, Veeva Oncology Link General Manager, talks about how the Oncology Link offering has evolved and how it facilitates the process of identifying and approaching key opinion leaders.

As part of its digital transformation, last year Novartis recruited Raj Patil, as Head of Data Strategy, and Shahram Ebadollahi as Head of Data Science and Advanced Analytics. Here they talk to Pharm Exec about the task that lies ahead.

Andre Heeg, Sandor's new Head of Digital, tells Pharm Exec about his digital vision for the company.

Hilary Hutton-Squire, Gilead’s UK & Ireland General Manager, talks to Pharm Exec about the company's new "HIV Age Positively" campaign.

Anjum Swaroop, Vice President and Head of IP at Dr. Reddy's, talks to Pharm Exec about her journey with the company and about what the future holds for this major US generics player.

As this year's ESMO gets under way, Pharm Exec spoke to James Campbell-global franchise business head at Merck KGaA, Darmstadt, Germany-to discuss his vision for the company as a global leader in oncology.

Pharm Exec speaks to Inovio Pharmaceutical's Dr. J. Joseph Kim about his journey from humble beginnings as an 11-year-old Korean immigrant to his present position at the forefront of a new medical frontier.

Pharm Exec talks to AELIX Therapeutics' Dr. José Luis Cabero about how the major career and country shift he made a decade ago have motivated and sustained a new direction in his career.

Over the last decade, Spain has seen a significant growth in venture-capital investment in the life sciences. We explore the driving forces.

At this month's AMPLEXOR Life Sciences’ “Be The Expert” conference, Pharm Exec caught up with Steve Gens, who talked about the evolution of Regulatory Information Management (RIM) and offered some predictions for 2022.

Pharm Exec speaks with Joe Wiley, CEO of Amryt Pharma, who is steering a road-less-traveled path for a small pharma-building a sustainable, commercial infrastructure first, with the hopes of accelerating new rare disease drugs to the market.

Ilyssa Levins talks to Pharm Exec about some of the regulatory, compliance and legal challenges posed by the digital health revolution.

IBM Watson Health's Peter Brandsetter talks about how analytics, IoT and artficial intelligence are moving from buzz words to real-world solutions with benefits that weren't possible just a few years ago.

Digital health is not at all about the app. It’s about the behavior of the individual patient, said Søren Smed Østergaard at this year's Digital Health World Congress in London.

CEO Helen Torley talks to Pharm Exec about her vision for Halozyme as a multi-product oncology biotech.

Pharm Exec talks to Rob Johnson, managing partner and co-founder of Alacrita, about pharma’s relationship with medical imaging.

To coincide with World Immunization Week, IFPMA's Thomas Cueni, chair of the AMR Industry Alliance, outlines the critical importance of vaccines in the fight against AMR and infectious diseases.

Practitioners in the field of HEOR training and education outline how the best courses are responding to advancing industry needs.

Looking at the balance of optimism and caution discussed at eyeforpharma Barcelona around pharma’s embrace of AI.

Pharm Exec speaks to James Burt, Accord Healthcare’s executive vice president, Europe and MENA, about the company’s vision for the UK and Europe post-Brexit, the challenges of retaining the company’s culture amid major growth, and the current landscape for generic medicines.

Saurabh Saha, Senior Vice President and Global Head of Translational Medicine at BMS, shares his perspectives on the current biomarker landscape, the role of translational medicine, and how BMS is working to advance biomarker research across their R&D portfolio.

Pharm Exec speaks to Jane Griffiths, Global Head of Actelion, about the current state of the industry's reputation and the work that needs to be done to further build trust with patients and the public.

Assembling a few rare slivers of pharma positivity on UK’s future.

A quick-fire interview with J&J’s Joanne Waldstreicher about the company’s “Advancing the Safe Use of Healthcare Products QuickFire Challenge”.